![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | abnormal circulating aspartate transaminase level | | IMP | | 13462048 | | RGD | | decreased circulating alanine transaminase level | | IMP | | 13462048 | | RGD | | decreased circulating bilirubin level | | IMP | | 13462048 | | RGD | | decreased circulating chloride level | | IMP | | 13462048 | | RGD | | decreased circulating potassium level | | IMP | | 13462048 | | RGD | | decreased circulating prolactin level | | IMP | | 13462048 | | RGD | | decreased circulating triglyceride level | | IMP | | 13462048 | | RGD | | decreased eosinophil cell number | | IMP | | 13462048 | | RGD | | decreased erythrocyte cell number | | IMP | | 12880447 | | RGD | | decreased hemoglobin content | | IMP | | 13462048 | | RGD | | decreased lymphocyte cell number | | IMP | | 13462048 | | RGD | | decreased surfactant secretion | | IMP | | 13462051 | | RGD | | enlarged alveolar lamellar bodies | | IMP | | 13462051 | | RGD | | hypersecretion of adrenocorticotropin | | IMP | | 13462048 | | RGD | | increased alveolar lamellar body number | | IMP | | 12880447 | | RGD | | increased body weight | | IMP | | 12880447 | | RGD | | increased brain size | | IMP | | 12880447 | | RGD | | increased brain weight | | IMP | | 12880447 | | RGD | | increased circulating cholesterol level | | IMP | | 12880447 | | RGD | | increased circulating creatinine level | | IMP | | 12880447 | | RGD | | increased circulating luteinizing hormone level | | IMP | | 13462048 | | RGD | | increased circulating serum albumin level | | IMP | | 13462048 | | RGD | | increased susceptibility to weight gain | | IMP | | 13462048 | | RGD | | |